Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.7 - $1.41 $5,170 - $10,414
7,386 Added 7.39%
107,386 $81,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $40.8 $122,000 - $4.08 Million
100,000 New
100,000 $130,000
Q1 2022

May 16, 2022

SELL
$2.96 - $7.76 $296,000 - $776,000
-100,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$7.4 - $11.66 $740,000 - $1.17 Million
100,000 New
100,000 $740,000
Q1 2021

May 14, 2021

SELL
$8.57 - $15.79 $2.81 Million - $5.17 Million
-327,500 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$5.98 - $12.47 $172,146 - $358,973
-28,787 Reduced 8.08%
327,500 $2.73 Million
Q3 2020

Nov 16, 2020

SELL
$4.65 - $8.73 $505,515 - $949,064
-108,713 Reduced 23.38%
356,287 $2.2 Million
Q2 2020

Aug 14, 2020

BUY
$4.66 - $8.7 $520,508 - $971,763
111,697 Added 31.62%
465,000 $3.87 Million
Q1 2020

May 15, 2020

BUY
$5.05 - $15.01 $285,193 - $847,674
56,474 Added 19.03%
353,303 $2.13 Million
Q4 2019

Feb 14, 2020

BUY
$6.32 - $19.66 $1.37 Million - $4.26 Million
216,829 Added 271.04%
296,829 $4.12 Million
Q3 2019

Nov 14, 2019

BUY
$8.03 - $14.82 $642,400 - $1.19 Million
80,000 New
80,000 $671,000
Q2 2019

Aug 14, 2019

SELL
$11.88 - $16.94 $1.17 Million - $1.66 Million
-98,150 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$17.44 - $17.95 $1.71 Million - $1.76 Million
98,150 New
98,150 $1.76 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $554M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.